8-K 1 c04506e8vk.htm FORM 8-K e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
Date of Report (Date of Earliest Event Reported):
  April 19, 2006
Rochester Medical Corporation
 
(Exact name of registrant as specified in its charter)
         
Minnesota   0-18933   41-1613227
         
(State or other jurisdiction
of incorporation) 		  (Commission
File Number) 		  (I.R.S. Employer
Identification No.)
         
One Rochester Medical Drive,
Stewartville, Minnesota 		     
55976
         
(Address of principal executive offices)       (Zip Code)
         
Registrant’s telephone number, including area code:   507-533-9600
Not Applicable
 
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

Item 2.02 Results of Operations and Financial Condition.
Item 9.01 Financial Statements and Exhibits.
SIGNATURES
Press Release

Table of Contents

Item 2.02 Results of Operations and Financial Condition.
Furnished herewith as Exhibit 99.1 and incorporated by reference herein is the text of Rochester Medical’s announcement regarding operating results for the second quarter ended March 31, 2006, as presented in a press release dated April 19, 2006.
Item 9.01 Financial Statements and Exhibits.
(c)    Exhibits.
Exhibit 99.1   Press Release dated April 19, 2006, issued by Rochester Medical Corporation.

 

Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  Rochester Medical Corporation
 		  
April 20, 2006  By:   /s/ David A. Jonas    
    Name:   David A. Jonas   
    Title:   Chief Financial Officer   

 

Table of Contents

Exhibit Index
         
     
Exhibit No.
  Description
 
   
99.1
 
Press Release dated April 19, 2006, issued by Rochester Medical Corporation